Sodium–Glucose Cotransporter Inhibitors Reduce Mortality and Morbidity in Patients With Heart Failure: Evidence From a Meta-Analysis of Randomized Trials
Conclusions:
Therefore, the available evidence supports the routine use of these drugs as standard-of-care, also given the highly favorable NNTs.
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Meta-analysis Source Type: research
More News: Cardiology | Cardiovascular | Databases & Libraries | Diabetes | Diabetes Type 2 | Drugs & Pharmacology | Endocrinology | Heart | Heart Failure | Study